Take a moment to check out Duke Translational Medicine Institute‘s story about a translational research collaboration between Duke and UNC:
The Duke University Translational Medicine Institute (DTMI) and the North Carolina Translational and Clinical Sciences Institute (NC TraCS) are launching a new program to award $50,000 grants for translational research projects that involve co-investigators – one from Duke and one from UNC.
“I think that although we come from different ends of Tobacco Road and our different shades of blue compete passionately in sports, when it comes to translating medical progress and health care to the community, we can be very collaborative,” said Jennifer Li, MD, MHS, professor of pediatrics and medicine, and co-PI of the Duke Translational Medicine Institute.
The pilot program is supported by the more than $100 million in funding to NC TraCS and DTMI as the academic homes of the National Institutes of Health’s Clinical and Translational Science Awards (CTSA) at UNC Chapel Hill and Duke University.
The new grants from the UNC and Duke CTSAs will encourage and facilitate novel clinical and translational research that applies or accelerates discovery into testing in clinical or population settings. They will place particular emphasis on cross-disciplinary discovery science research addressing the development of therapies, diagnostics or devices applicable to human disease and clinical trials.
The new program will award funding to projects that demonstrate high translational potential with a clear path to subsequent grant support, new company formation, licensing, not-for-profit partnering, or other channels. The deadline for proposals is October 31, 2014.